Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Book part

Version

Published version

Publication date

Publication license

cc by (c) García Rodríguez, Julio César et al., 2012
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/174405

Neuro-EPO by Nasal Route as a Neuroprotective Therapy in Brain Ischemia

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Cerebral vascular diseases (CVD) are the third leading cause of death in industrialized countries and in Cuba affect the 50% of the population above 60 years old. The mortality is exponentially increased with age and doubles every five years. A total of 22,000 annual cases are estimated in Cuba, a country where life expectance should increase to 80 years in the near future [1]. CVD are often followed by a high social and individual cost as a consequence of disability and family affectation. The most problematic among such diseases is ischemic cerebral vascular disease, characterized by the reduction of cerebral blood flow (CBF) below a critical level. From this initial event several processes take place to induce the clinical symptoms of cerebral ischemia...

Citation

Citation

GARCÍA RODRÍGUEZ, Julio César and RAMA BRETÓN, Ramón. Neuro-EPO by Nasal Route as a Neuroprotective Therapy in Brain Ischemia. Chapter 3 in: García Rodríguez. J. C. 2012. Acute Ischemic Stroke. ISBN: 978-953-307-983-7. DOI: 10.5772/1438. pp. 59-78. [consulted: 9 of August of 2026]. Available at: https://hdl.handle.net/2445/174405

Export metadata

JSON - METS

Share record